Kumud Kalia Guardant Health, Inc. (GH) insider trading activity

Kumud Kalia is Chief Information Officer of Guardant Health, Inc.. Currently has a direct ownership of 18,850 shares of GH, which is worth approximately $1.25 Million. The most recent transaction as insider was on Sep 01, 2025, when has been sold 361 shares (Common Stock) at a price of $67.42 per share, resulting in proceeds of $24,338. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 18.9K

0.45% 3M change

2.97% 12M change

Total Value Held $1.25 Million

Kumud Kalia Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 01 2025	SELL Payment of exercise price or tax liability	$24,338 $67.42 p/Share	361 Reduced 1.88%	18,850 Common Stock
Sep 01 2025	BUY Exercise of conversion of derivative security	-	711 Added 3.57%	19,211 Common Stock
Aug 21 2025	SELL Open market or private sale	$123,520 $61.76 p/Share	2,000 Reduced 9.76%	18,500 Common Stock
Jul 01 2025	SELL Payment of exercise price or tax liability	$69,219 $50.71 p/Share	1,365 Reduced 6.24%	20,500 Common Stock
Jul 01 2025	BUY Exercise of conversion of derivative security	-	2,691 Added 10.96%	21,865 Common Stock
Jun 15 2025	SELL Payment of exercise price or tax liability	$11,238 $49.29 p/Share	228 Reduced 1.18%	19,174 Common Stock
Jun 15 2025	BUY Exercise of conversion of derivative security	-	637 Added 3.18%	19,402 Common Stock
Jun 03 2025	SELL Open market or private sale	$185,560 $46.39 p/Share	4,000 Reduced 17.57%	18,765 Common Stock
Jun 01 2025	SELL Payment of exercise price or tax liability	$10,317 $40.62 p/Share	254 Reduced 1.1%	22,765 Common Stock
Jun 01 2025	BUY Exercise of conversion of derivative security	-	710 Added 2.99%	23,019 Common Stock
Apr 01 2025	SELL Payment of exercise price or tax liability	$40,813 $42.47 p/Share	961 Reduced 4.29%	21,450 Common Stock
Apr 01 2025	BUY Exercise of conversion of derivative security	-	2,691 Added 10.72%	22,411 Common Stock
Mar 17 2025	SELL Open market or private sale	$151,060 $43.16 p/Share	3,500 Reduced 15.07%	19,720 Common Stock
Mar 15 2025	SELL Payment of exercise price or tax liability	$9,778 $42.89 p/Share	228 Reduced 0.97%	23,220 Common Stock
Mar 15 2025	BUY Exercise of conversion of derivative security	-	637 Added 2.64%	23,448 Common Stock
Mar 01 2025	SELL Payment of exercise price or tax liability	$67,654 $42.55 p/Share	1,590 Reduced 6.52%	22,811 Common Stock
Mar 01 2025	BUY Exercise of conversion of derivative security	-	4,406 Added 15.29%	24,401 Common Stock
Jan 01 2025	SELL Payment of exercise price or tax liability	$33,696 $30.55 p/Share	1,103 Reduced 5.23%	19,995 Common Stock
Jan 01 2025	BUY Exercise of conversion of derivative security	-	2,690 Added 11.31%	21,098 Common Stock
Dec 15 2024	SELL Payment of exercise price or tax liability	$11,227 $34.76 p/Share	323 Reduced 1.72%	18,408 Common Stock
Dec 15 2024	BUY Exercise of conversion of derivative security	-	637 Added 3.29%	18,731 Common Stock
Dec 01 2024	SELL Payment of exercise price or tax liability	$12,819 $35.61 p/Share	360 Reduced 1.95%	18,094 Common Stock
Dec 01 2024	BUY Exercise of conversion of derivative security	-	710 Added 3.7%	18,454 Common Stock
Nov 18 2024	SELL Open market or private sale	$204,750 $29.25 p/Share	7,000 Reduced 28.29%	17,744 Common Stock
Oct 01 2024	SELL Payment of exercise price or tax liability	$65,917 $22.12 p/Share	2,980 Reduced 10.75%	24,744 Common Stock

Kumud Kalia

Chief Information Officer

Redwood City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GH shares.

Notify only if

Value

Insider Trading

Get notified when an Guardant Health, Inc. insider buys or sells GH shares.

Notify only if

Operation

Value

Type

News

Receive news related to Guardant Health, Inc.

Track Activities on GH

Account